<table width="90%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1. Summary of Mean (±SD) Pharmacokinetic Parameters in Patients <footnote>Advanced solid tumor cancers, primarily of the lung</footnote> with Solid Tumors Receiving Intravenous Epirubicin 60 to 150 mg/m<sup>2</sup></caption>
<col align="center" width="16%"></col>
<col align="center" width="17%"></col>
<col align="center" width="17%"></col>
<col align="center" width="17%"></col>
<col align="center" width="17%"></col>
<col align="center" width="16%"></col>
<thead>
<tr><th stylecode="Rrule">Dose <footnote>N=6 patients per dose level</footnote><br/> (mg/m<sup>2</sup> )</th><th stylecode="Rrule">C<sub>max</sub><footnote>Plasma concentration at the end of 6 to 10 minute infusion</footnote><br/> (µg/mL)</th><th stylecode="Rrule">(µg∙h/mL)<br/> AUC <footnote>Area under the plasma concentration curve</footnote></th><th stylecode="Rrule">t 1/2 <footnote>Half-life of terminal phase</footnote><br/> (hours)</th><th stylecode="Rrule">CL<footnote>Plasma clearance</footnote><br/> (L/hour)</th><th>Vss<footnote>Steady state volume of distribution</footnote><br/> (L/kg)</th></tr>
</thead>
<tbody>
<tr stylecode="Botrule"><td stylecode="Rrule">60</td><td stylecode="Rrule">5.7± 1.6</td><td stylecode="Rrule">1.6 ± 0.2</td><td stylecode="Rrule">35.3± 9</td><td stylecode="Rrule">65 ± 8</td><td>21 ± 2</td></tr>
<tr stylecode="Botrule"><td stylecode="Rrule">75</td><td stylecode="Rrule">5.3± 1.5</td><td stylecode="Rrule">1.7 ± 0.3</td><td stylecode="Rrule">32.1± 5</td><td stylecode="Rrule">83 ± 14</td><td>27 ± 11</td></tr>
<tr stylecode="Botrule"><td stylecode="Rrule">120</td><td stylecode="Rrule">9.0± 3.5</td><td stylecode="Rrule">3.4 ± 0.7</td><td stylecode="Rrule">33.7± 4</td><td stylecode="Rrule">65 ± 13</td><td>23 ± 7</td></tr>
<tr><td stylecode="Rrule">150</td><td stylecode="Rrule">9.3± 2.9</td><td stylecode="Rrule">4.2 ± 0.8</td><td stylecode="Rrule">31.1± 6</td><td stylecode="Rrule">69 ± 13</td><td>21 ± 7</td></tr>
</tbody>
</table>